BSH 2023 | Session overview: improving treatment for patients with ITP
In this video, Nichola Cooper, MD, FRCP, FRCPath, Imperial College London, London, UK, provides an overview of a session which took place at BSH 2023 regarding autoimmune hematology and immune thrombocytopenia (ITP). Dr Cooper discusses the main topics of the session, including improving access to thrombopoietin receptor (TPOR) agonists, managing patients who have additional immunodeficiency disorders, recognizing the value of genomic testing, transitioning from first-generation to second-generation TPOR agonists, and developing strategies for patients who fail rituximab therapy. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
